Sotorasib contraindicated population: severe liver injury, pregnant patients' instructions, and management of joint pain and vomiting

The contraindications for Lumakras/AMG510 mainly include patients with severe liver injury and pregnant women, and strict adherence to medicati...

Precautions for taking sotaloxib: hepatotoxicity, interstitial lung disease, and diarrhea

As a targeted drug, the monitoring and management of adverse reactions such as liver toxicity, interstitial lung disease, and diarrhea should b...

Sotorasib: Usage, Dosage, Resistance Mechanism, and Precautions

Sutoraxib (trade name Lumakras/AMG510) is a targeted drug used for specific cancers, with a standard dose of 960mg orally per day. Attention sh...

Sotorasib: Guidelines for KRAS G12C inhibitor therapy for NSCLC

Sotorasib is the first approved KRASG12C targeted inhibitor for the treatment of non-small cell lung cancer (NSCLC) carrying this mutation. The...

Fasturtec contraindicated population: G6PD deficiency, previous allergy patients need to know

The contraindications for Fasturtec include patients with G6PD deficiency and previous allergies, and strict screening is necessary to avoid se...

Managing the side effects of Rabelase: How to deal with fever, vomiting, and rash

The possible side effects such as fever, vomiting, and rash during treatment with Fasturtec require targeted management. The following systemat...

Precautions for using Rabelase: risk of hemolysis, G6PD deficiency, and allergic reactions

When using Fasturtec for the treatment of hyperuricemia in tumor lysis syndrome, special attention should be paid to the risk of hemolysis, c...

Fasturtec: Guidelines for the treatment of hyperuricemia in tumor lysis syndrome

Precautions for taking Indian Haideronib: bleeding risk, atrial fibrillation, and infection monitoring

Ibrutinib, as a BTK inhibitor, should focus on the risks of bleeding, atrial fibrillation, and infection. Regular monitoring of relevant indica...

Ibrutinib: Usage, Dosage and Precautions

Ibrutinib is a BTK inhibitor primarily used for the treatment of B-cell malignancies and chronic graft-versus-host disease. The usage and dosag...